Navigation Links
Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder
Date:4/24/2008

commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health. Vermillion is based in Fremont, California. Additional information about Vermillion can be found on the Web at http://www.vermillion.com.

Forward Looking Statements

This news release contains forward-looking statements that involve significant risks and uncertainties, including statements regarding Vermillion's plans, objectives, expectations and intentions. These forward- looking statements are based on Vermillion's current expectations. The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for such forward-looking statements. In order to comply with the terms of the safe harbor, Vermillion notes that a variety of factors could cause actual results and experience to differ materially from the anticipated results or other expectations expressed in such forward-looking statements. There are no guarantees that Vermillion will succeed in its efforts to commercialize TTP diagnostic products in 2008 or during any other period of time. Factors that could cause actual results to materially differ include but are not limited to: (1) uncertainty in obtaining intellectual property protection for inventions made by Vermillion; (2) unproven ability of Vermillion to discover, develop, and commercialize TTP diagnostic products based on findings from its disease association studies; (3) unproven ability of Vermillion to discover or identify new protein biomarkers and use such information to develop TTP diagnostic products; (4) uncertainty as to whether Vermillion will be able to obtain any required regulatory approval of its TTP diagnostic products; (5) uncertainty of market acceptance of its TTP diagnostic products, inclu
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
2. Vermillion Receives Award From the Society of Gynecologic Oncologists
3. Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles Snuffy Myers Announces Vitamin D Clinical Trials
4. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
5. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
6. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
7. SuperGens MP-470 Sensitizes Prostate and Breast Cancer Cells to Erlotinib
8. Microwave Treatments for Enlarged Prostate Cause Blood Pressure Surges
9. Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure
10. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
11. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014  Novation, the leading health care supply chain ... value-added reseller (VAR) national contracts that expand its portfolio ... at lower costs. These include manufacturer product and service ... assistance and ongoing IT consulting support. ...
(Date:1/15/2014)... OAKS, Calif. , Jan. 15, 2014 ... Amgen (NASDAQ: AMGN ) announced today ... jointly discover and validate new therapeutic targets and ... a chronic disorder that affects millions worldwide. The ...
(Date:1/15/2014)... WORTH, Texas , Jan. 15, 2014  Humberto C. ... Dermatology Achievement Award" from the Journal of Drugs ... Aesthetic & Clinical Conference (ODAC). The event is January 17-20, ... Florida . The ODAC ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... 2011 Columbia Laboratories, Inc. (Nasdaq: CBRX ... ), today announced the publication of Phase III PROCHIEVE® ... Ultrasound in Obstetrics & Gynecology , the leading peer-reviewed ... & Gynecology. The published results indicate ...
... SAN DIEGO, April 6, 2011 ... a leading global medical technology company, today announced ... of pharmaceutical waste, helping hospitals reduce cost, improve ... (Photo:   http://photos.prnewswire.com/prnh/20110406/LA78173 ) (Logo:   ...
Cached Medicine Technology:Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 2Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 3Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 4Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 5Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 6Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 7Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results 8CareFusion Acquires Technology for Sorting and Managing Dangerous Pharmaceutical Waste 2CareFusion Acquires Technology for Sorting and Managing Dangerous Pharmaceutical Waste 3
(Date:4/22/2014)... may throw tantrums like toddlers, but their total ... say, a gerbil or fox squirrel, according to ... and birds ranging from orangutans to zebra finches. ... Yale and more than two-dozen other research institutions ... evolution of self-control, defined in the study as ...
(Date:4/22/2014)... LOS ANGELES (April 22, 2014) Cedars-Sinai stroke intervention ... Neurological Disorders and Stroke, part of the National Institutes ... fund a multicenter Phase II clinical trial of an ... will be used in combination with recombinant tissue plasminogen ... to treat ischemic strokes shortly after onset. In laboratory ...
(Date:4/22/2014)... We,ve all waited in line and most of us ... we would like. , For Will Mather, assistant ... of Science,s Integrated Science Curriculum, studying lines, or queues, ... deal with bottlenecks that limit the recycling of proteins. ... an assistant professor, has received attention from the National ...
(Date:4/22/2014)... A new prediction tool can help doctors better identify ... after surgery and therefore prevent the often deadly condition, ... the May issue of Anesthesiology . , Affecting ... (ARDS) is a sudden failure of the lungs caused ... to pneumonia or blood infection. High-risk patients can develop ...
(Date:4/21/2014)... OAK BROOK, Ill. Imaging of the coronary arteries ... of arterial plaque and could have a dramatic impact ... high risk of heart attacks and other cardiovascular events, ... the journal Radiology . , Plaque that forms ... in some cases, rupture, leading to potentially fatal heart ...
Breaking Medicine News(10 mins):Health News:Brain size matters when it comes to animal self-control 2Health News:Brain size matters when it comes to animal self-control 3Health News:$8 million NIH grant will fund multicenter clinical trial of stroke intervention drug 2Health News:$8 million NIH grant will fund multicenter clinical trial of stroke intervention drug 3Health News:Queuing theory helps physicist understand protein recycling 2Health News:New tool helps doctors better predict, prevent deadly respiratory failure 2Health News:CT measures potentially dangerous arterial plaque in diabetic patients 2Health News:CT measures potentially dangerous arterial plaque in diabetic patients 3
... could boost sensitivity, amount of information offered by the ... could some day be injected into the body to ... amount of information provided by the images, according to ... act as "smart tags" that identify specific cells, tissues, ...
... of Survivor Cafe Continues Longstanding ... Community Support By Binson,s, DETROIT, June 18 The fight ... Komen Detroit Race for,the Cure(R) with the participation of 344 participants from ... the Komen Race for the Cure Series has been a celebration,of life, ...
... research awards to states in 2007 created more than ... from those new jobs, and,spurred more than $50 billion ... for NIH Threatens New Health Research, U.S.,Medical Leadership, and ... Institutes,of Health has a legacy of great medical accomplishments, ...
... VW Bus For Fundraising Contest, HERNDON, Va., June ... their hands on legendary rock band The Who,s Magic,Bus ... 1965, signed by Roger,Daltrey and Pete Townshend and specially ... target logo. The competition, in aid of Daltrey,s,charity Teenage ...
... June 21, 2008, New Alternatives,for Children (NAC), a New ... disabilities and/or chronic illnesses, will,hold its 3rd Annual NAC ... 12:00 noon to 3:30 pm rain or shine., ... family members,are expected to participate in the 2008 NAC ...
... June 18 After 25 years, 26 chapters,and more ... the brink of a new era. And, beginning in ... alike can read the latest news,and cutting-edge technologies with ... available, in its entirety, online, offering readers,more opportunities to ...
Cached Medicine News:Health News:'Micromagnets' May One Day Enhance MRI Technology 2Health News:Fight Against Breast Cancer Receives Big Boost During Susan G. Komen Detroit Race for the Cure(R) With 344 Participants From Binson's, Northwood 2Health News:Fight Against Breast Cancer Receives Big Boost During Susan G. Komen Detroit Race for the Cure(R) With 344 Participants From Binson's, Northwood 3Health News:Fight Against Breast Cancer Receives Big Boost During Susan G. Komen Detroit Race for the Cure(R) With 344 Participants From Binson's, Northwood 4Health News:Report: NIH and Global Health Research are a Major Boon to All State Economies 2Health News:Report: NIH and Global Health Research are a Major Boon to All State Economies 3Health News:Volkswagen Partners With Legendary Rock Band 'The Who' To Raise Money for Teenage Cancer Trust Charity 2Health News:Volkswagen Partners With Legendary Rock Band 'The Who' To Raise Money for Teenage Cancer Trust Charity 3Health News:2008 NAC Kids Olympics Celebrates the Achievements and Persevering Spirits of Hundreds of Children with Disabilities and Chronic Illnesses on Saturday, June 21, 2008 at Riverbank State Park 2Health News:2008 NAC Kids Olympics Celebrates the Achievements and Persevering Spirits of Hundreds of Children with Disabilities and Chronic Illnesses on Saturday, June 21, 2008 at Riverbank State Park 3Health News:Dermatology Nurses' Association Teams with International Publisher to Launch its Own Journal 2Health News:Dermatology Nurses' Association Teams with International Publisher to Launch its Own Journal 3
... The Foundation® PS knee offers a femoral option ... cam action that engages at 60 degrees of ... motion and allow for 130 degrees of flexion. ... design with prominent lateral flare. The constrained tibial ...
... System is designed to provide the surgeon ... clinical indications. Based on the clinically successful ... P.F.C. SIGMA continues a history of innovation ... to address implant longevity by maximizing femoro-tibial ...
... Knee System's curved-on-curved articulation maintains full inter-changeability. ... for better patient fit. The Maxim ... knee's proven concepts with expanded options to ... Maxim is indicated for use in total ...
... laser combines excellent cutting, ablation and ... procedures. It is also extremely effective ... stones of all compositions, making it ... its laser light is transmitted through ...
Medicine Products: